|
|
|
Insider
Information: |
Henney Christopher S |
Relationship: |
Director |
City: |
Seattle |
State: |
WA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
1,304,748 |
|
Indirect Shares
|
100,000 |
|
|
Direct
Value |
$15,372 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
1,404,748 |
|
|
Total
Value |
$15,372 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
Percentage
Gain/Loss : |
0.0%
|
-56.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Dendreon Corp |
DNDN |
Chaiman of the Board, ... |
2004-02-17 |
1,062,904 |
2003-07-28 |
0 |
Premium* |
|
Techne Corp |
TECH |
Director |
2004-09-17 |
0 |
2003-08-20 |
0 |
Premium* |
|
Sgx Pharmaceuticals, Inc. |
SGXP |
Director |
2008-08-20 |
0 |
|
0 |
Premium* |
|
Cascadian Therapeutics, Inc |
CASC |
Director |
2018-03-09 |
0 |
2007-12-10 |
0 |
Premium* |
|
Anthera Pharmaceuticals Inc |
ANTH |
Director |
2012-06-29 |
202,429 |
2012-06-29 |
100,000 |
Premium* |
|
Prothena Corp Plc |
PRTA |
Director |
2021-07-14 |
0 |
2015-08-07 |
0 |
Premium* |
|
Cyclacel Pharmaceuticals Inc |
CYCC |
Director |
2023-06-30 |
39,415 |
2021-06-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CYCC |
Cyclacel Pharmaceuticals ... |
Director |
|
2023-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
21,219 |
39,415 |
0 |
- |
|
CYCC |
Cyclacel Pharmaceuticals ... |
Director |
|
2022-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
15,822 |
18,196 |
0 |
- |
|
PRTA |
Prothena Corp Plc |
Director |
|
2021-07-14 |
4 |
AS |
$55.31 |
$616,020 |
D/D |
(11,108) |
0 |
0 |
% |
|
PRTA |
Prothena Corp Plc |
Director |
|
2021-07-14 |
4 |
OE |
$11.33 |
$125,854 |
D/D |
11,108 |
11,108 |
0 |
- |
|
PRTA |
Prothena Corp Plc |
|
|
2021-07-12 |
4 |
S |
$53.84 |
$1,326,128 |
D/D |
(23,892) |
0 |
0 |
% |
|
PRTA |
Prothena Corp Plc |
|
|
2021-07-12 |
4/A |
AS |
$53.84 |
$1,326,128 |
D/D |
(23,892) |
0 |
0 |
- |
|
PRTA |
Prothena Corp Plc |
|
|
2021-07-12 |
4 |
OE |
$9.23 |
$233,946 |
D/D |
23,892 |
6,392 |
0 |
- |
|
PRTA |
Prothena Corp Plc |
Director |
|
2021-06-25 |
4 |
S |
$47.57 |
$572,819 |
D/D |
(12,000) |
0 |
0 |
% |
|
PRTA |
Prothena Corp Plc |
Director |
|
2021-06-25 |
4 |
OE |
$16.43 |
$197,160 |
D/D |
12,000 |
12,000 |
0 |
- |
|
CYCC |
Cyclacel Pharmaceuticals ... |
Director |
|
2021-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,374 |
2,374 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2018-03-09 |
4 |
D |
$0.00 |
$0 |
D/D |
(60,185) |
0 |
0 |
- |
|
PRTA |
Prothena Corp Plc |
Director |
|
2017-09-28 |
4 |
AS |
$70.00 |
$63,000 |
D/D |
(900) |
0 |
0 |
- |
|
PRTA |
Prothena Corp Plc |
Director |
|
2017-09-28 |
4 |
OE |
$6.65 |
$5,985 |
D/D |
900 |
900 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2017-09-24 |
4 |
D |
$3.94 |
$2,340 |
D/D |
(594) |
60,185 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2017-09-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,375 |
60,779 |
0 |
- |
|
PRTA |
Prothena Corp Plc |
Director |
|
2017-07-17 |
4 |
AS |
$66.13 |
$330,671 |
D/D |
(5,000) |
0 |
0 |
- |
|
PRTA |
Prothena Corp Plc |
Director |
|
2017-07-17 |
4 |
OE |
$6.65 |
$33,250 |
D/D |
5,000 |
5,000 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2017-06-24 |
4 |
D |
$3.78 |
$8,562 |
D/D |
(2,265) |
58,404 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2017-06-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,058 |
60,669 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2017-06-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,148 |
52,148 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2017-06-12 |
4 |
D |
$3.34 |
$1,794 |
D/D |
(537) |
51,611 |
0 |
- |
|
PRTA |
Prothena Corp Plc |
Director |
|
2017-02-27 |
4 |
OE |
$6.65 |
$39,827 |
D/D |
5,989 |
5,989 |
0 |
- |
|
PRTA |
Prothena Corp Plc |
Director |
|
2017-02-27 |
4 |
AS |
$57.16 |
$342,350 |
D/D |
(5,989) |
0 |
0 |
- |
|
PRTA |
Prothena Corp Plc |
Director |
|
2017-02-17 |
4 |
AS |
$57.06 |
$228,880 |
D/D |
(4,011) |
0 |
0 |
- |
|
PRTA |
Prothena Corp Plc |
Director |
|
2017-02-17 |
4 |
OE |
$6.65 |
$26,673 |
D/D |
4,011 |
4,011 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|